Esoteric Testing Market Size, Share & Industry Report [2032]

Esoteric Testing Market Size, Share & Industry Report [2032]

Segments - Esoteric Testing Market by Type (Oncology Testing, Genetic Testing, Immunology Testing, Infectious Diseases Testing, Endocrinology Testing, Toxicology Testing, Neurology Testing, and Others), Technology (Enzyme-linked Immunosorbent Assay, Mass Spectrometry, DNA Sequencing, Chemiluminescence Immunoassay, Real Time Polymerase Chain Reaction, Flow Cytometry, and Others), End-user (Independent and Reference Laboratories and Hospital-based Laboratories), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-6535 | 4.9 Rating | 54 Reviews | 242 Pages | Format : PDF Excel PPT

Report Description


Esoteric Testing Market Outlook 2032

The global esoteric testing market size was USD 18.7 Billion in 2023 and is projected to reach USD 58.45 Billion by 2032, expanding at a CAGR of 13.5% during 2024–2032. The market growth is attributed to the growing awareness of esoteric testing.

Increasing demand for personalized medicine is boosting the esoteric testing market in the coming years. Personalized medicine relies heavily on advanced diagnostic techniques to tailor treatments to individual patients based on their genetic makeup and disease characteristics. Esoteric tests offer precise insights into a patient's unique biology, enabling healthcare providers to make informed treatment decisions. Moreover, the surging adoption of novel personalized medicine approaches approved by governing agencies further fueling the demand for esoteric testing solutions.

  • According to the report published on April 17, 2024, personalized medicines comprised 21% of the total FDA-approved new molecular entities in 2014. By 2023, this proportion had risen to 38%.

Esoteric Testing Market Outlook

Impact of Artificial Intelligence (AI) in Esoteric Testing Market

The use of artificial intelligence is likely to boost the esoteric testing market. AI-powered predictive analytics identify patterns and trends in patient data, which facilitates early disease detection and personalized treatment strategies. Furthermore, AI-enabled robotic automation enhances laboratory operations, from sample processing to result reporting, ensuring precision and reliability.

Esoteric Testing Market Dynamics

Esoteric Testing Market Dynamics

Major Drivers

Growing prevalence of chronic diseases is anticipated to boost the market during the forecast period. Chronic diseases, such as cancer, cardiovascular disorders, and diabetes impose a burden on healthcare systems worldwide. Esoteric tests detect and monitor chronic conditions, enabling timely intervention and personalized treatment strategies. Furthermore, these platforms offer rapid and sensitive detection methods, which further boosts their demand in the coming years.

  • As per the report published on December 18, 2023, around 60% of adults in the US live with chronic conditions like cancer, heart disease, or diabetes.

Existing Restraints

High cost associated with esoteric testing procedures is expected to hamper the market. These tests often involve sophisticated technologies and specialized reagents, which results in elevated testing costs as compared to conventional diagnostic tests. Moreover, the limited awareness and understanding of esoteric testing among healthcare professionals and patients further hinder the market.

Emerging Opportunities

­Growing investment in R&D activities is likely to create immense opportunities for the players competing in the market. Pharmaceutical companies are focusing on addressing unmet clinical needs and expanding the utility of esoteric tests across diverse medical applications. Furthermore, increasing focus on early disease detection and preventive healthcare initiatives fuels the demand for esoteric testing services.

Scope of the Esoteric Testing Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Attributes

Details

Report Title

Esoteric Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2023

Historic Data

2017 -2022

Forecast Period

2024–2032

Segmentation

Type (Oncology Testing, Genetic Testing, Immunology Testing, Infectious Diseases Testing, Endocrinology testing, Toxicology Testing, Neurology Testing, and Others), Technology (Enzyme-linked Immunosorbent Assay, Mass Spectrometry, DNA Sequencing, Chemiluminescence Immunoassay, Real Time Polymerase Chain Reaction, Flow Cytometry, and Others), and End-user (Independent and Reference Laboratories and Hospital-based Laboratories)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

ARUP Laboratories; Athena Esoterix, LLC; Bruker; F. Hoffmann-La Roche Ltd; Laboratory Corporation of America® Holdings; Mayo Foundation for Medical Education and Research (MFMER); Quest Diagnostics; and Sonic Healthcare Limited

Regional Outlook

In terms of region, the global esoteric testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023, due to the presence of strong healthcare infrastructure and advanced diagnostic capabilities, make it conducive to the adoption of esoteric testing services. Additionally, favorable reimbursement policies facilitate the widespread availability and accessibility of esoteric tests in this region.

The market in Asia Pacific is projected to grow at a significant pace in the years to come, owing to the rising healthcare expenditure in countries, including China, India, and Japan creates a high demand for advanced diagnostic solutions, including esoteric tests. Moreover, the growing burden of chronic and infectious diseases in the region further fuels the demand for esoteric testing services.

Esoteric Testing Market Segment Insights

Type Segment Analysis

Based on type, the esoteric testing market is divided into oncology testing, genetic testing, immunology testing, infectious diseases testing, endocrinology testing, toxicology testing, neurology testing, and others. The oncology segment is expected to expand at a significant pace in the coming years, increasing incidence of cancer globally.

Esoteric tests help in identifying actionable mutations, predicting treatment responses, and monitoring disease progression in cancer patients. For instance, according to the report published by the WHO on February 3, 2022, cancer is a leading cause of death globally, resulting in nearly 10 million deaths in 2020. Moreover, advancements in genomic technologies, such as next-generation sequencing (NGS) and liquid biopsy enable personalized medicine approaches. These all factors contribute to boosting the market.

Esoteric Testing Market Type

Technology Segment Analysis

On the basis of technology, the global market is segregated into enzyme-linked immunosorbent assay, mass spectrometry, DNA sequencing, chemiluminescence immunoassay, real time polymerase chain reaction, flow cytometry, and others. The mass spectrometry segment held largest market share in 2023, as they offer high sensitivity, specificity, and multiplexing capabilities, making them well-suited for a wide range of esoteric testing applications. Additionally, the expanding applications of mass spectrometry in biomarker discovery, therapeutic drug monitoring, and toxicology testing further boost their demand.

The DNA sequencing segment is anticipated to expand at a substantial CAGR during the forecast period, owing to the growing demand for affordable DNA sequencing-based esoteric tests. Moreover, expanding applications of DNA sequencing in epigenomics, transcriptomics, and metagenomics further fuels the segment in the coming years.

Esoteric Testing Market Technology

End-user Segment Analysis

Based on end-user, the esoteric testing market is segmented into independent and reference laboratories and hospital-based laboratories. The independent and reference laboratories segment is projected to register a robust growth during the assessment years.

Independent laboratories offer greater flexibility, scalability, and specialization in esoteric testing services and catering to the diverse needs of healthcare settings. Moreover, independent laboratories often leverage advanced technologies, automation, and expertise to deliver high-quality esoteric testing solutions with rapid turnaround times and superior accuracy. These factors are fueling the segment during the forecast period.

Segments

The esoteric testing market has been segmented on the basis of

Type

  • Oncology Testing
  • Genetic Testing
  • Immunology Testing
  • Infectious Diseases Testing
  • Endocrinology testing
  • Toxicology Testing
  • Neurology Testing
  • Others

Technology

  • Enzyme-linked Immunosorbent Assay
  • Mass Spectrometry
  • DNA Sequencing
  • Chemiluminescence Immunoassay
  • Real Time Polymerase Chain Reaction
  • Flow Cytometry
  • Others

End-user

  • Independent and Reference Laboratories
  • Hospital-based Laboratories

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • ARUP Laboratories
  • Athena Esoterix, LLC
  • Bruker
  • F. Hoffmann-La Roche Ltd
  • Laboratory Corporation of America® Holdings
  • Mayo Foundation for Medical Education and Research (MFMER)
  • Quest Diagnostics
  • Sonic Healthcare Limited

Competitive Landscape

Key players competing in the global esoteric testing market are ARUP Laboratories; Athena Esoterix, LLC; Bruker; F. Hoffmann-La Roche Ltd; Laboratory Corporation of America Holdings; Mayo Foundation for Medical Education and Research (MFMER); Quest Diagnostics; and Sonic Healthcare Limited.

These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide. For instance,

  • On May 2, 2024, Bruker, a biotechnology solutions provider, announced the acquisition of ELITechGroup for EUR 870 million, excluding the carved-out ELITech clinical chemistry business. This acquisition enhances Bruker's portfolio in biomedical systems/specialty IVD, molecular diagnostics (MDx), and microbiology.

    Esoteric Testing Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Esoteric Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Esoteric Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Esoteric Testing Market - Supply Chain
  4.5. Global Esoteric Testing Market Forecast
     4.5.1. Esoteric Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Esoteric Testing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Esoteric Testing Market Absolute $ Opportunity
5. Global Esoteric Testing Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Esoteric Testing Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Esoteric Testing Demand Share Forecast, 2019-2026
6. North America Esoteric Testing Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Esoteric Testing Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Esoteric Testing Demand Share Forecast, 2019-2026
7. Latin America Esoteric Testing Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Esoteric Testing Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Esoteric Testing Demand Share Forecast, 2019-2026
8. Europe Esoteric Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Esoteric Testing Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Esoteric Testing Demand Share Forecast, 2019-2026
9. Asia Pacific Esoteric Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Esoteric Testing Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Esoteric Testing Demand Share Forecast, 2019-2026
10. Middle East & Africa Esoteric Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Esoteric Testing Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Esoteric Testing Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Esoteric Testing Market: Market Share Analysis
  11.2. Esoteric Testing Distributors and Customers
  11.3. Esoteric Testing Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. ARUP Laboratories
     11.4.2. Athena Esoterix, LLC
     11.4.3. Bruker
     11.4.4. F. Hoffmann-La Roche Ltd
     11.4.5. Laboratory Corporation of America® Holdings
     11.4.6. Mayo Foundation for Medical Education and Research (MFMER)
     11.4.7. Quest Diagnostics
     11.4.8. Sonic Healthcare Limited

Methodology

Our Clients

FedEx Logistics
Honda Motor Co. Ltd.
Deloitte
Siemens Healthcare
Dassault Aviation
Nestle SA
Pfizer
The John Holland Group